CUSIP 15673T100COMIPSCQ4 2025
32 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | 5.96M | $5.93M |
| 2 | Dafna Capital Management LLC | 2.79M | $2.78M |
| 3 | Vanguard Group Inc | 2.10M | $2.09M |
| 4 | Adage Capital Partners Gp, L.L.C. | 1.84M | $1.83M |
| 5 | Two Sigma Investments, LP | 1.50M | $1.49M |
| 6 | Spruce Street Capital LP | 1.42M | $1.41M |
| 7 | Renaissance Technologies LLC | 1.35M | $1.34M |
| 8 | Two Sigma Advisers, LP | 1.27M | $1.26M |
| 9 |
| 4 | Jan 16, 2026 | Ra Capital Management, L.P. | 13G | 9.9% | 17.94M | SEC |
| 5 | Jan 15, 2026 | Tcg Crossover Gp II, LLC | 13G | 11.0% | 17.75M | SEC |
| 6 | Jan 15, 2026 | Deep Track Capital, LP | 13G | 7.3% | 13.49M | SEC |
| 7 | Jan 5, 2026 | Point72 Asset Management, L.P. | 13G | 5.4% | 4.73M | SEC |
| 8 | Nov 14, 2025 | Bain Capital Life Sciences Opportunities III, LP | 13G/A | 4.1% | 3.54M | SEC |
| 9 | May 15, 2025 | Casdin Capital, LLC | 13G/A | 3.7% | 32.12T | SEC |
| 10 | Feb 14, 2025 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 4.7% | 3.96M | SEC |
See the full Schedule 13D/13G history for Century Therapeutics Inc.
Unlock full history| Casdin Capital, LLC |
| 1.23M |
| $1.22M |
| 10 | Syncona Portfolio Ltd | 1.21M | $1.21M |